GW Pharma


GW Pharma (GWPH) Stock Could Surge on Earnings Today

GW Pharma (GWPH) has the distinction of having the first two cannabis-derived prescription drugs that were approved by the FDA: Epidiolex and Sativex.  …

GW Pharma (GWPH) Stock Gets Price-Target Hike Following FDA Approval

There’s a new FDA-approved cannabis-based medicine on the scene. Today, the U.

Top Analyst Initiates Buy on GW Pharmaceuticals PLC- ADR (GWPH); Sees 45% Upside for the Stock

In a research report released on Friday, Goldman Sachs top analyst Salveen Richter initiated coverage on shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) with a …

We Continue To Recommend GWPH Based On Epidiolex’s Potential, Says Cowen

Cowen analyst Phil Nadeau reiterated an Outperform rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $110, following the news that the company’s first Phase …

UPDATE: Piper Jaffray Maintains Buy On GW Pharmaceuticals Following Sativex Phase III Results

In a research report published today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $147, …